What is the CVR number of Q-TECH MEDICARE ApS?

Q-TECH MEDICARE ApS is registered with CVR / Virk under CVR 26480434.

What is the revenue of Q-TECH MEDICARE ApS?

Q-TECH MEDICARE ApS reported revenue of DKK -13K in 2024.

How many employees does Q-TECH MEDICARE ApS have?

Q-TECH MEDICARE ApS employs 1 people as of the latest annual report.

Who is the CEO of Q-TECH MEDICARE ApS?

Poul Rexen Thomsen is Audit of Q-TECH MEDICARE ApS, in role since 2002.

Where is Q-TECH MEDICARE ApS headquartered?

Q-TECH MEDICARE ApS's registered address is Violhaven 25.

Q-TECH MEDICARE ApS

APSActive

CVR 26480434Violhaven 25Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20021 employees

Revenue 2024

DKK -13K

-5% vs 2023

EBITDA margin

100.0%

+5% vs 2023

Equity ratio

24.8%

Financial strength

Net profit 2024

DKK -13K

+6% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -13K	-5%
EBITDA	DKK -13K	+5%
Net profit	DKK -13K	+6%
Total assets	DKK 31K	-15%
Equity	DKK 8K	-62%
Employees	1	—

Item	2020	2021	2022	2023	2024
Revenue	-10	11	-8	-14	-13
Staff expenses	-0	-0	-0	-0	-0
EBITDA	-10	11	-8	-14	-13
Depreciation & amort.	-0	-0	-0	-0	-0
EBIT	-10	11	-8	-14	-13
Net financials	-0	0	-0	0	0
Profit before tax	-10	11	-9	-14	-13
Tax	-0	-0	-0	-0	-0
Net profit	-10	11	-9	-14	-13

Item	2020	2021	2022	2023	2024
Total assets	51	48	42	37	31
Equity	32	43	34	21	8
Long-term debt	0	0	0	0	0
Short-term debt	20	5	8	16	23
Total debt	20	5	8	16	23

Name	Role	Member since
Current (2)
AR Axel Rasmussen Founder	Founder	2002
SQ Suzanne Qvist Christiansen Management	Management	2006
Former (1)
PR Poul Rexen Thomsen Audit	Audit	2002 – 2007

Shareholder	Type	Ownership	Votes	Since
QTM HOLDING ApS	Company	100%	100%	2008

Person	Role here	Other companies
Poul Rexen Thomsen	Audit	0 companies
Axel Rasmussen	Founder	0 companies
Suzanne Qvist Christiansen	Management	0 companies

Q-TECH MEDICARE ApS

APSActive

CVR 26480434Violhaven 25Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20021 employees

Revenue 2024

DKK -13K

-5% vs 2023

EBITDA margin

100.0%

+5% vs 2023

Equity ratio

24.8%

Financial strength

Net profit 2024

DKK -13K

+6% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -13K	-5%
EBITDA	DKK -13K	+5%
Net profit	DKK -13K	+6%
Total assets	DKK 31K	-15%
Equity	DKK 8K	-62%
Employees	1	—